Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Staar Surgical Company
This study will be conducted at up to 20 clinical sites in the United States by surgeons qualified by training and experience to implant STAAR ICLs.
Age
21–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Moderate to high myopia or myopic astigmatism correctable with available EVO/EVO+ ICL powers.
Stable refractive history within 0.50 D each cylinder and spherical equivalent (SE) for 1 year prior to implantation.
Able and willing to return for scheduled follow-up examinations after surgery.
Able to read, understand and provide written informed consent on the Institutional Review Board (IRB)-approved informed consent form (ICF) and provide authorization as appropriate for local privacy regulations.
You may not be if
Insulin-dependent diabetes or diabetic retinopathy.
History of previous ocular surgery.
Cataract of any grade.
Monocular.
Pregnant or nursing women, or those who plan to become pregnant over the course of this clinical study.
Clareo Health | Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)
